Insilico Medicine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-powered Drug Discovery Robotics Laboratory

  • Written by Auzzi Shopping
BEIJING, CHINA - Media OutReach - 6 June 2022 - Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with expertise in investing in the biopharmaceutical and life sciences sectors.

More Articles ...

  1. WEAVE LIVING and PGIM REAL ESTATE Join Forces for a USD200 Million Urban Living Joint Venture
  2. AXA launches "AXA Climate School for university students in Hong Kong"
  3. Hantec Financial will attend Wiki Finance Expo 2022 in Vietnam, HCMC
  4. Pump Up Your Adrenaline With iShopChangi’s iShopathon
  5. Summer sensation on display in Denkendorf – baby allosaurus "Little Al" has arrived!
  6. International Cancer Specialists Provides Low-Dose CT Scans For Safer Lung Cancer Screening
  7. NTUC LearningHub To Innovate And Grow Under New Leadership Team
  8. XLD Launches xSpend in Malaysia, allows users to spend Crypto Assets for Utilities
  9. Apical Wins Five Awards at the Sustainable Business Awards Indonesia 2020/2021
  10. Sino Jet Announces Carbon Neutrality Plan

Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 18

Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 2 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 3 in /httpdocs/templates/gk_university/html/pagination.php on line 34